Skip to main content
. 2017 Jan 10;6(2):374–381. doi: 10.1002/cam4.949

Figure 6.

Figure 6

Ceria nanoparticles (CNPs)‐AL‐PEG600 promoted the growth of HepG2 cells in vivo.(A) HepG2 cells were subcutaneously injected into the right flank to establish xenograft models, and mice were intraperitoneally injected with CNPs‐AL‐PEG600 or PBS, once every 2 days, at a dose of 0.01 mg/kg. Low dose CNPs‐AL‐PEG600 promoted the growth of HepG2 cells in vivo; (B, C) The tumor weight in each group. (*P < 0.05 compared to the control group).